Featured Articles
Trending Articles
Nivolumab Plus Chemotherapy Demonstrates Significant Survival Benefit in Resectable NSCLC
Clinical Trials | 22 February 2025
How SkinJect's Microneedle Technology Could Transform the Treatment of Skin Cancer
ONCOLife | 5 March 2025
KEYTRUDA Receives Priority FDA Review for Perioperative Use in ES Head and Neck Cancer
FDA & EMA | 26 February 2025
Odronextamab Gains FDA Review for Hard-to-Treat R/R Follicular Lymphoma
FDA & EMA | 26 February 2025
Enhertu Gains EMA’s CHMP Support for HER2-Low Metastatic Breast Cancer Treatment
FDA & EMA | 28 February 2025
No More Doubts: CDK 4/6 inhibitor + ET as First-Line Standard for HR+ mBC
ONCOLife | 24 February 2025
Patient Enrollment Completed in VAPOR 2 Trial for Vanquish Prostate Cancer Therapy
Clinical Trials | 25 February 2025
How Bayer Shapes Strategic Partnerships for the Next Generation of Cancer Therapies
ONCOLife | 20 February 2025
AI in Life Sciences: Trends and Predictions for 2025 - By Doron Sitbon
AI | 21 February 2025
DNA-Based Immunotherapy IMNN-001 Promises to Improve Survival in Ovarian Cancer
Clinical Trials | 19 February 2025
New Data Confirms Darolutamide’s Safety and Efficacy in mHS Prostate Cancer
ONCOLife | 14 February 2025
How AI Innovations Are Transforming Breast Cancer Screening
ONCOLife | 30 January 2025
Dr. Rafael Rosell Discusses the Efficacy of KRAS G12C Inhibitor in Lung Cancer Treatment
ONCOLife
5 August 2024
FDA Approves Sotorasib and Panitumumab Combo for KRAS G12C+ Colorectal Cancer
FDA & EMA
17 January 2025
FDA Approves 225Ac-SSO110 Radiopharmaceutical Trial for Small Cell Lung Cancer
FDA & EMA
14 January 2025
How AI Could Overcome Data Scarcity to Transform Medicine
AI
10 January 2025
First-Ever Obstructive Sleep Apnea Drug, Zepbound, Approved by FDA for Obesity
FDA & EMA
21 December 2024
FDA Approves BRAFTOVI Combo as First-Line Treatment for Colorectal Cancer
FDA & EMA
20 December 2024
The Recombinant Polyclonal Drug Candidate GIGA-2339 for Hepatitis B Treatment
Webinar
19 December 2024
Ribociclib Shows Promising Long-Term Benefits in Early Breast Cancer Treatment
Clinical Trials
12 December 2024
Palbociclib Combination Yields PFS Improvement in HR+, HER2+ Breast Cancer
Clinical Trials
14 December 2024
Olaparib Shows Long-term Survival Benefits in BRCA+ and HER2- Breast Cancer
Clinical Trials
13 December 2024
IL-15 Agonist NKTR-255 Enhances CAR-T Therapy Effectiveness in LB-Cell Lymphoma
Clinical Trials
11 December 2024
AbbVie Acquires Nimble in $200 Million Deal to Strengthen Immunology Pipeline
Pharma
13 December 2024